| Ytd | -49.28% | |
| 1y | -50.22% |
| Open | 4.51 | Prev Close | 4.42 | Low | 4.45 | High | 4.71 | Mkt Cap | 512.21M |
| Vol | 3.33M | Avg Vol | 3.97M | EPS | -1.08 | P/E | -4.22 | Forward P/E | -11.61 |
| Beta | 1.90 | Short Ratio | 1.71 | Inst. Own | 10.35% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-28 | 50-d Avg | 4.59 | 200-d Avg | 7.42 | 1yr Est | 1.78 |
Tilray's revenue rose by 11% in the 2026 fiscal year. Opportunities in international cannabis market
ELTON, United Kingdom, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Scottish craft brewer BrewDog , by Tilray B
There is a great divide between big cannabis companies like Trulieve cannabis corp. Tilray Holdings
The company's true organic growth is difficult to gauge given its high dependency on acquisitions.
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Tilray's distribution segment was the only one that generated double-digit growth in its most recent
Tilray Inc (NASDAQ:TLRY) is making progress in its transition into a diversified consumer products c
Tilray Brands stock continued its strong downtrend and is hovering at its lowest level since June la
Tilray Inc (NASDAQ:TLRY) is making progress in its transition into a diversified consumer products c
Tilray Brands delivered strong Q4 revenue growth, driven by the BrewDog acquisition, but shares hit
Tilray Brands, Inc. (TLRY) Q4 2026 Earnings Call Transcript
Tilray Brands, Inc. (TLRY) came out with a quarterly loss of $0.43 per share versus the Zacks Consen
Tilray Brands NASDAQ: TLRY reported record fiscal 2026 revenue and adjusted EBITDA, supported by gro
Record Fiscal Year Net Revenue of $ 915 Million, Record Gross Profit, Consistent Adjusted Gross Marg
Tilray reports Q4 earnings tonight with its full-year EBITDA guidance on the line, a fresh BrewDog a
New spirits line brings the bold blood orange and honey profile of Revolver's iconic Blood & Honey b
TORONTO, July 23, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq:
The cannabis industry continues evolving despite ongoing regulatory uncertainty across North America
Tilray Brands, Inc. (TLRY) closed the most recent trading day at $4.23, moving 1.63% from the previo
Tilray's growth rate has been improving in recent quarters, and if that trend continues, it could he
BrewDog and Tilray are keeping football's biggest celebration alive by unlocking the £1 million bar
TD Cowen analyst Robert Moskow maintains Tilray Brands (NASDAQ:TLRY) with a Buy and lowers the pr
https://www.benzinga.com/markets/equities/26/06/53113507/trump-says-iran-took-too-long-and-will-pay-
https://www.marijuanamoment.net/white-house-pushes-congress-to-keep-hemp-cbd-products-legal-by-amend
https://www.marijuanamoment.net/marijuana-components-have-consistent-anti-tumor-effec
Akanda Corp. (NASDAQ: AKAN) stock surges over 50% Wednesday. Learn how DOJ regulatory shifts and low
Akanda stock surges as U.S. moves to reclassify marijuana, lifting cannabis stocks and fueling stron
SoFi Technologies faces volatility ahead of April 29 earnings. Read our technical breakdown, key sup
https://apnews.com/article/medical-marijuana-rescheduling-justice-department-trump-cannabis-1d6722d3
Akanda Corp. shares jump 33.69% after hours following a 214% intraday surge.
Cannabis ETFs surge as Trump signals Schedule III reclassification, boosting profit outlook and inve
Trump is reportedly set to reclassify marijuana this week, but Polymarket traders put the odds at ju
https://www.axios.com/2026/04/22/trump-marijuana-rule-change
Top Wall Street analysts upgraded WING, TLRY, EAT, OLLI, CHA stocks. Analysts have mixed views on EA
Here's the earnings calendar for the holiday-shortened week of March 30, 2026, including reports
https://www.marijuanamoment.net/white-house-schedules-meeting-on-cannabis-products-enforcement-polic
https://www.marijuanamoment.net/marijuana-businesses-could-list-on-us-stock-exchanges-like-nasdaq-an
https://cannabiswire.com/newsletters/scoop-medicare-cbd-pilot-will-allow-some-thc-in-products/?free_
https://www.marijuanamoment.net/federal-agency-finalized-rule-for-cbd-medicare-coverage-pilot-progra
https://www.marijuanamoment.net/gop-congressman-isnt-sure-marijuana-rescheduling-is-a-doj-priority-b
Dan Ahrens analyzes Trump's historic cannabis shift. Learn how Schedule 3 could end the 280E 
https://www.marijuanamoment.net/new-hampshire-house-passes-bills-to-legalize-marijuana-and-let-dispe
https://www.marijuanamoment.net/congressional-leaders-drop-attempt-to-block-marijuana-rescheduling-w
https://www.marijuanamoment.net/florida-attorney-general-asks-supreme-court-to-block-marijuana-legal
https://www.marijuanamoment.net/federal-health-programs-will-cover-up-to-500-worth-of-cbd-for-certai
https://themarijuanaherald.com/2025/12/president-trump-directs-attorney-general-pam-bondi-to-finaliz
https://www.marijuanamoment.net/supreme-court-should-uphold-gun-ban-for-marijuana-users-19-state-ags